We reached out to all those that were on it and we gave them a period of time when we offered coaching and other programs to them
Instruct patients to discontinue SAXENDA promptly and contact their healthcare provider if pancreatitis is suspected [see WARNINGS AND PRECAUTIONS ]
Mounjaro is classified as a glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor agonist
Allulose alone does not cause weight loss because it provides minimal calories and only modestly elevates GLP-1 compared to prescription medications
Common side effects: Headache Upper respiratory infection symptoms (sore throat, runny/stuffy nose) Constipation Vomiting Mouth ulcers Rare but serious side effects (seek medical attention): Heart failure (shortness of breath, swelling, sudden weight gain) Pancreatitis (persistent nausea/vomiting, severe abdominal/back pain) Allergic reactions (hives, facial swelling, difficulty breathing) Hypoglycemia when combined with insulin or sulfonylureas (hunger, sweating, confusion) Kidney problems (decreased function, failure requiring dialysis) Severe skin reactions (blisters, skin erosion) Severe joint pain What should you tell your healthcare provider before taking Januvia
How Common Is Muscle Loss with GLP-1/GIP Therapy
